Opportunity ID: 274995

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 18
Posted Date: Mar 06, 2015
Last Updated Date: May 27, 2015
Original Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 02, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

Version History

Version Modification Description Updated Date
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. May 27, 2015
Jun 18, 2016
Jun 18, 2016
Jun 18, 2016
May 27, 2015
May 27, 2015
The purpose of Admendment 2 is to change the due date to June 2, 2015 May 27, 2015
The purpose of Amendment 1 to this FOA is to provide additional clarifying information based on questions received from potential applicants
during the Pre-Application Informational Conference Call held on March 11, 2015. A summary of the questions and answers can be found in
Section H. Other Information beginning on page 39 of the amended FOA.
May 27, 2015
The purpose of Amendment 1 to this FOA is to provide additional clarifying information based on questions received from potential applicants
during the Pre-Application Informational Conference Call held on March 11, 2015. A summary of the questions and answers can be found in
Section H. Other Information beginning on page 39 of the amended FOA.
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
Mar 27, 2015
The correct closing date for this FOA is May 8, 2015, please retrieve a new application package from Grants.gov with the correct closing date.
LCB
Mar 27, 2015
The correct closing date for this FOA is May 8, 2015, please retrieve a new application package from Grants.gov with the correct closing date.
LCB
Mar 13, 2015
Mar 13, 2015

DISPLAYING: Synopsis 18

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 18
Posted Date: Mar 06, 2015
Last Updated Date: May 27, 2015
Original Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 02, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Forecast 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Forecast 3
Posted Date: Jun 18, 2016
Last Updated Date: Jun 18, 2016
Original Closing Date for Applications:
Current Closing Date for Applications:
Archive Date: May 30, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities. The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused.  For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the awardee will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes.

Additional Information

Agency Name:
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:


Email:EUW9@cdc.gov

DISPLAYING: Forecast 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Forecast 2
Posted Date: Jun 18, 2016
Last Updated Date: Jun 18, 2016
Original Closing Date for Applications:
Current Closing Date for Applications:
Archive Date: May 30, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. The award floor is $750,000 and the award ceiling is $1,000,000 for this FOA. CDC will consider any application that is beyond or below these parameters as non-responsive and it will receive no further review. Applicants must provide a LOS from a state-level law enforcement authority in their state. The LOS must show that the authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants must provide a LOS from the PDMP authority in their state showing the authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP Applicants must provide a LOS from the state authority managing the entity where the work under the “implement insurer and health systems” priority strategy is focused. For example, if a proposal is for creating an opioid management program for the Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from that authority. If the applicant is integrating and/or disseminating CDC Opioid Prescribing Guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state be using for evaluation. For example, provide a LOS from law enforcement agencies or medical boards if their data is to be used in evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes.

Additional Information

Agency Name:
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:


Email:EUW9@cdc.gov

DISPLAYING: Forecast 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Forecast 1
Posted Date: Jun 18, 2016
Last Updated Date: Jun 18, 2016
Original Closing Date for Applications:
Current Closing Date for Applications:
Archive Date: Jun 04, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. The award floor is $750,000 and the award ceiling is $1,000,000 for this FOA. CDC will consider any application that is beyond or below these parameters as non-responsive and it will receive no further review. Applicants must provide a LOS from a state-level law enforcement authority in their state. The LOS must show that the authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants must provide a LOS from the PDMP authority in their state showing the authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP Applicants must provide a LOS from the state authority managing the entity where the work under the “implement insurer and health systems” priority strategy is focused. For example, if a proposal is for creating an opioid management program for the Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from that authority. If the applicant is integrating and/or disseminating CDC Opioid Prescribing Guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to the data being used for evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes.

Additional Information

Agency Name:
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:


Email:EUW9@cdc.gov

DISPLAYING: Synopsis 17

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 17
Posted Date: May 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 02, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 16

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 16
Posted Date: May 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 02, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 15

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 15
Posted Date: May 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC/PGO’

770-488-2700

Email:pgotim@cdc.gov

DISPLAYING: Synopsis 14

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 14
Posted Date: May 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross

EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 13

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 13
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 12

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 12
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 11

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 11
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 10

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 10
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 9

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 9
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 8

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 8
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 7

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 7
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 6

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 6
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 5

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 5
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Mar 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross

EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 13, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CE15-1501
Funding Opportunity Title: Prescription Drug Overdose Prevention for States
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 16
Assistance Listings: 93.136 — Injury Prevention and Control Research and State and Community Based Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 13, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jun 07, 2015
Estimated Total Program Funding: $55,600,000
Award Ceiling: $1,000,000
Award Floor: $750,000

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.
Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.
Applicants must provide a Letter of Support (LOS) from:

A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.
The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.
The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.

Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.
If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Gross
EUW9@cdc.gov

Email:EUW9@cdc.gov

Folder 274995 Full Announcement-1 -> ce15-1501#2amendment.pdf

Packages

Agency Contact Information: Eric Gross
EUW9@cdc.gov

Email: EUW9@cdc.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.136 CDC-RFA-CE15-1501 Prescription Drug Overdose Prevention for States PKG00215371 Mar 06, 2015 Jun 02, 2015 View

Package 1

Mandatory forms

274995 SF424_2_1-2.1.pdf

274995 SF424A-1.0.pdf

274995 HHS_CheckList_2_1-2.1.pdf

274995 Project-1.1.pdf

274995 Budget-1.1.pdf

Optional forms

274995 Other-1.1.pdf

2025-07-14T12:53:03-05:00

Share This Post, Choose Your Platform!

About the Author: